MARKET

SPRO

SPRO

Spero Therapeuti
NASDAQ
2.290
-0.020
-0.87%
After Hours: 2.385 +0.095 +4.17% 17:26 12/18 EST
OPEN
2.330
PREV CLOSE
2.310
HIGH
2.335
LOW
2.280
VOLUME
290.86K
TURNOVER
--
52 WEEK HIGH
3.220
52 WEEK LOW
0.5052
MARKET CAP
129.02M
P/E (TTM)
-2.8809
1D
5D
1M
3M
1Y
5Y
1D
Evercore ISI Keeps Their Hold Rating on Spero Therapeutics (SPRO)
TipRanks · 13h ago
Weekly Report: what happened at SPRO last week (1208-1212)?
Weekly Report · 3d ago
Weekly Report: what happened at SPRO last week (1201-1205)?
Weekly Report · 12/08 09:50
Weekly Report: what happened at SPRO last week (1124-1128)?
Weekly Report · 12/01 09:48
Spero Therapeutics Grants 90,000 RSUs to New Employee Under Inducement Plan
Reuters · 11/28 13:00
SPERO THERAPEUTICS ANNOUNCES INDUCEMENT GRANT UNDER NASDAQ LISTING RULE 5635(C)(4)
Reuters · 11/28 13:00
Weekly Report: what happened at SPRO last week (1117-1121)?
Weekly Report · 11/24 09:51
Weekly Report: what happened at SPRO last week (1110-1114)?
Weekly Report · 11/17 09:51
More
About SPRO
Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying and developing novel treatments for rare diseases and diseases caused by multi-drug resistant (MDR) bacterial infections with unmet need. Its product candidate SPR720 is an investigational, chemically stable phosphate ester prodrug that is converted in vivo to SPR719 for the treatment of nontuberculous mycobacterial (NTM) pulmonary disease. Its clinical stage product candidate, tebipenem HBr is an investigational oral carbapenem antibiotic being developed for the treatment of complicated urinary tract infections (cUTIs) including acute pyelonephritis (AP) to help patients potentially reduce duration of in-patient therapy.

Webull offers Spero Therapeutics Inc stock information, including NASDAQ: SPRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPRO stock methods without spending real money on the virtual paper trading platform.